Cohen: Price Drugs on Value, Not R&D
Though pharmaceutical companies point to research and development costs to justify how they price drugs, a product's… Read more
HEOR Feature
Featured
Venture Capitalist Chimes in on Drug Pricing Debate
Bruce Booth, Atlas Venture partner, offers several suggestions for future drug pricing reform in a recent article published on Forbes. Among his… Read more
Hospitals Increase Spending on Cancer Immunotherapies
Hospitals are allocating more of their budgets toward new cancer and migraine treatments amid ongoing concerns over prescription drug prices,… Read more
Analysis: Vote on Correvio’s Brinavess Shows RWE, RWD Not a Guarantee
Correvio Pharma posted another loss for its heart drug Brinavess this week following an FDA advisory committee's 11-2 vote against the drug. The… Read more
